Drug Facts
Composition & Profile
Identifiers & Packaging
HOW SUPPLIED Ciclopirox Olamine Topical Suspension USP, 0.77% (w/w) (Lotion) is available as follow: NDC: 72162-1406-3: 30 mL in a BOTTLE NDC: 72162-1406-6: 60 mL in a BOTTLE Bottle space provided to allow for vigorous shaking before each use. Repackaged/Relabeled by: Bryant Ranch Prepack, Inc. Burbank, CA 91504; Ciclopirox Olamine 0.77% Lotion, USP 30 mL Label
- HOW SUPPLIED Ciclopirox Olamine Topical Suspension USP, 0.77% (w/w) (Lotion) is available as follow: NDC: 72162-1406-3: 30 mL in a BOTTLE NDC: 72162-1406-6: 60 mL in a BOTTLE Bottle space provided to allow for vigorous shaking before each use. Repackaged/Relabeled by: Bryant Ranch Prepack, Inc. Burbank, CA 91504
- Ciclopirox Olamine 0.77% Lotion, USP 30 mL Label
Overview
Ciclopirox Olamine Topical Suspension USP, 0.77% (w/w) (Lotion) is for topical use. Each gram of Ciclopirox Olamine Topical Suspension USP, 0.77% (w/w) (Lotion) contains 7.70 mg of ciclopirox (as ciclopirox olamine) in a water miscible suspension base consisting of benzyl alcohol (1% as a preservative), cetyl alcohol, lactic acid, light mineral oil, myristyl alcohol, octyldodecanol, polysorbate 60, purified water, sorbitan monostearate, and stearyl alcohol. Ciclopirox Olamine Topical Suspension USP, 0.77% (w/w) (Lotion) contains a synthetic, broad-spectrum, antifungal agent ciclopirox (as ciclopirox olamine). The chemical name is 6-cyclohexyl-1-hydroxy-4-methyl-2(1 H )-pyridone, 2-aminoethanol salt. The CAS Registry Number is 41621-49-2. Ciclopirox Olamine Topical Suspension USP, 0.77% (w/w) (Lotion) has a pH of 7. The chemical structure is:
Indications & Usage
Ciclopirox Olamine Topical Suspension USP, 0.77% (w/w) (Lotion) is indicated for the topical treatment of the following dermal infections: tinea pedis, tinea cruris and tinea corporis due to Trichophyton rubrum, Trichophyton mentagrophytes, Epidermophyton floccosum, and Microsporum canis; cutaneous candidiasis (moniliasis) due to Candida albicans; and tinea (pityriasis) versicolor due to Malassezia furfur .
Dosage & Administration
Gently massage Ciclopirox Olamine Topical Suspension USP, 0.77% (w/w) (Lotion) into the affected and surrounding skin areas twice daily, in the morning and evening. Clinical improvement with relief of pruritus and other symptoms usually occurs within the first week of treatment. If a patient shows no clinical improvement after four weeks of treatment with Ciclopirox Olamine Topical Suspension USP, 0.77% (w/w) (Lotion) the diagnosis should be redetermined. Patients with tinea versicolor usually exhibit clinical and mycological clearing after two weeks of treatment.
Warnings & Precautions
WARNINGS General - Ciclopirox Olamine Topical Suspension USP, 0.77% (w/w) (Lotion) is not for ophthalmic use. Keep out of reach of children.
Contraindications
Ciclopirox Olamine Topical Suspension USP, 0.77% (w/w) (Lotion) is contraindicated in individuals who have shown hypersensitivity to any of its components.
Adverse Reactions
In the controlled clinical trial with 89 patients using ciclopirox olamine topical suspension and 89 patients using the vehicle, the incidence of adverse reactions was low. Those considered possibly related to treatment or occurring in more than one patient were pruritus, which occurred in two patients using ciclopirox olamine topical suspension and one patient using the suspension vehicle, and burning, which occurred in one patient using ciclopirox olamine topical suspension.
Storage & Handling
Store at 20° to 25° C (68° to 77° F) [see USP Controlled Room Temperature].
Similar Drugs
Related medications based on brand, generic name, substance, active ingredients.